Growth Metrics

Bio-Rad Laboratories (BIO) Deferred Taxes (2015 - 2017)

Bio-Rad Laboratories (BIO) reported Deferred Taxes of -$5.3 million for Q3 2017, down 142.66% year-over-year from $12.5 million in Q3 2016, and down 284.83% on a QoQ basis from $2.9 million in Q2 2017.

Bio-Rad Laboratories (BIO) has 3 years of Deferred Taxes data on file, last reported at -$5.3 million in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -33.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -101.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -9.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 300,000.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -16.70 Mn
10 Bio-Rad Laboratories 8.23 Bn 6.66 Bn 309.40 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2017 -5.35 Mn
Jun 30, 2017 2.89 Mn
Mar 31, 2017 163,000.00
Sep 30, 2016 12.54 Mn
Jun 30, 2016 -666,000.00
Mar 31, 2016 -3.39 Mn
Sep 30, 2015 -2.73 Mn